Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;11(3):70.
doi: 10.3390/jcdd11030070.

Cardiopulmonary Exercise Testing in Heart Failure

Michel Juarez  1 , Cristian Castillo-Rodriguez  1 , Dina Soliman  1 , Gaspar Del Rio-Pertuz  2 , Kenneth Nugent  1
Affiliations
Review

Cardiopulmonary Exercise Testing in Heart Failure

Michel Juarez et al. J Cardiovasc Dev Dis. .

Abstract

Cardiopulmonary exercise testing (CPET) provides important information for the assessment and management of patients with heart failure. This testing measures the respiratory and cardiac responses to exercise and allows measurement of the oxygen uptake (V˙O2) max and the relationship between minute ventilation (V˙E) and carbon dioxide excretion (V˙CO2). These two parameters help classify patients into categories that help predict prognosis, and patients with a V˙O2 < 14 mL/kg/min and V˙E/V˙CO2 slope >35 have a poor prognosis. This testing has been used in drug trials to determine complex physiologic responses to medications, such as angiotensin-converting enzyme inhibitors. For example, a study with enalapril demonstrated that the peak V˙O2 was 14.6 ± 1.6 mL/kg/min on placebo and 15.8 ± 2.0 mL/kg/min on enalapril after 15 days of treatment. The V˙E/V˙CO2 slopes were 43 ± 8 on placebo and 39 ± 7 on enalapril. Chronic heart failure and reduced physical activity measured by cardiopulmonary exercise testing are associated with increases in BNP, and several studies have demonstrated that cardiac rehabilitation is associated with reductions in BNP and increases in V˙O2. Therefore, BNP measurements can help determine the benefits of cardiac rehabilitation and provide indirect estimates of changes in V˙O2. In addition, measurement of microRNAs can determine the status of skeletal muscle used during physical activity and the changes associated with rehabilitation. However, CPET requires complicated technology, and simpler methods to measure physical activity could help clinicians to manage their patients. Recent advances in technology have led to the development of portable cardiopulmonary exercise testing equipment, which can be used in various routine physical activities, such as walking upstairs, sweeping the floor, and making the bed, to provide patients and clinicians a better understanding of the patient's current symptoms. Finally, current smart watches can provide important information about the cardiorespiratory system, identify unexpected clinical problems, and help monitor the response to treatment. The organized use of these devices could contribute to the management of certain aspects of these patients' care, such as monitoring the treatment of atrial fibrillation. This review article provides a comprehensive overview of the current use of CPET in heart failure patients and discusses exercise principles, methods, clinical applications, and prognostic implications.

Keywords: cardiopulmonary exercise testing; heart failure; prognosis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cardiopulmonary exercise results: 9 panels.
Figure 2
Figure 2
The use of CPET to classify patients and make estimates of outcomes.
See this image and copyright information in PMC

References

    1. Mapelli M., Salvioni E., Mattavelli I., Vignati C., Galotta A., Magrì D., Apostolo A., Sciomer S., Campodonico J., Agostoni P. Cardiopulmonary exercise testing and heart failure: A tale born from oxygen uptake. Eur. Heart J. Suppl. 2023;25((Suppl. C)):C319–C325. doi: 10.1093/eurheartjsupp/suad057. - DOI - PMC - PubMed
    1. Watanabe T., Tohyama T., Ikeda M., Fujino T., Hashimoto T., Matsushima S., Kishimoto J., Todaka K., Kinugawa S., Tsutsui H., et al. Development of Deep-Learning Models for Real-Time Anaerobic Threshold and Peak V˙O2 Prediction during Cardiopulmonary Exercise Testing. Eur. J. Prev. Cardiol. 2023 doi: 10.1093/eurjpc/zwad375. - DOI - PubMed
    1. Ingle L. Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail. Rev. 2007;12:12–22. doi: 10.1007/s10741-007-9000-y. - DOI - PubMed
    1. Magrì D., Gallo G., Parati G., Cicoira M., Senni M. Risk stratification in heart failure with mild reduced ejection fraction. Eur. J. Prev. Cardiol. 2020;27:59–64. doi: 10.1177/2047487320951104. - DOI - PMC - PubMed
    1. De Souza I.M.A., Da Silveira A.D., Stein R., Ramos J.S.P., Ribeiro R.S., Pazelli A.M., De Oliveira Q.B., Darze E.S., Ritt L.F. Independent and additional value of cardiopulmonary exercise test to the New York Heart Association classification in heart failure. J. Am. Coll. Cardiol. 2022;79:1440. doi: 10.1016/S0735-1097(22)02431-7. - DOI

LinkOut - more resources